Avet Pharmaceuticals appoints George Svokos as President &CEO
George Svokos joins Avet after serving as a strategic business advisor to numerous global healthcare companies
George Svokos joins Avet after serving as a strategic business advisor to numerous global healthcare companies
ICRA expects the OPM of the sample set to moderate to 20.2% in FY2023 from 21.5% in FY2022.
The objective of this Phase 1 study is to determine the safety and tolerability of OLX10212 in patients with advanced AMD at multiple sites in the US.
The over-the-counter market has long been an important segment of Glenmark’s portfolio around the world
This facility will produce higher efficacy products that enjoy greater acceptance and enhanced profit marginsg
ANI’s Clorazepate Dipotassium Tablets are the generic version of the Reference Listed Drug (RLD) Tranxene.
U.S. FDA has issued Form 483 with six observations after an inspection of the company’s formulation manufacturing facility based out of Baddi
Ex-Azithromycin has shown a growth of 8% and 14% in April 2022 and May 2022 respectively
The company is strategically expanding its product portfolio with a pipeline of new products that will form a strong foundation for future growth.
Becomes the first airline globally to develop and launch sustainable, temperature-controlled containers for the transportation of pharmaceuticals
Subscribe To Our Newsletter & Stay Updated